On November 6, 2023, Wall Street Zen upgraded its rating for Structure Therapeutics (NASDAQ: GPCR) from “sell” to “hold.” This decision reflects a shift in sentiment...
On November 28, 2023, Wall Street Zen upgraded Structure Therapeutics (NASDAQ: GPCR) from a “sell” rating to a “hold” rating. This change comes as a part...
Pharvaris (NASDAQ: PHVS) has recently been upgraded by Wall Street Zen from a “sell” rating to a “hold” rating, reflecting a positive shift in investor sentiment...
Analysts on Wall Street delivered significant updates on Friday, October 27, 2023, affecting several key technology and consumer companies. Among the notable calls were upgrades for...
Investment firm Morgan Stanley has upgraded its rating for ASML, moving from “equal weight” to “overweight.” This decision reflects the firm’s confidence that the demand for...
PROCEPT BioRobotics (NASDAQ: PRCT) has been assigned a neutral rating by BTIG Research, reflecting a cautious outlook for the company. The rating was reissued in a...
